| Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 A Trkola, M Purtscher, T Muster, C Ballaun, A Buchacher, N Sullivan, ... Journal of virology 70 (2), 1100-1108, 1996 | 1407 | 1996 |
| Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems A García-Sastre, A Egorov, D Matassov, S Brandt, DE Levy, JE Durbin, ... Virology 252 (2), 324-330, 1998 | 1356 | 1998 |
| A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 T Muster, F Steindl, M Purtscher, A Trkola, A Klima, G Himmler, F Rüker, ... Journal of virology 67 (11), 6642-6647, 1993 | 1289 | 1993 |
| Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon X Wang, M Li, H Zheng, T Muster, P Palese, AA Beg, A Garcı́a-Sastre Journal of virology 74 (24), 11566-11573, 2000 | 790 | 2000 |
| Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein J Talon, CM Horvath, R Polley, CF Basler, T Muster, P Palese, ... Journal of virology 74 (17), 7989-7996, 2000 | 782 | 2000 |
| Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication M Bergmann, A Garcia-Sastre, E Carnero, H Pehamberger, K Wolff, ... Journal of virology 74 (13), 6203-6206, 2000 | 525 | 2000 |
| Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS T Muster, R Guinea, A Trkola, M Purtscher, A Klima, F Steindl, P Palese, ... Journal of virology 68 (6), 4031-4034, 1994 | 401 | 1994 |
| Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach J Talon, M Salvatore, RE O'Neill, Y Nakaya, H Zheng, T Muster, ... Proceedings of the National Academy of Sciences 97 (8), 4309-4314, 2000 | 400 | 2000 |
| Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells A Egorov, S Brandt, S Sereinig, J Romanova, B Ferko, D Katinger, ... Journal of virology 72 (8), 6437-6441, 1998 | 306 | 1998 |
| An endogenous retrovirus derived from human melanoma cells T Muster, A Waltenberger, A Grassauer, S Hirschl, P Caucig, I Romirer, ... Cancer research 63 (24), 8735-8741, 2003 | 226 | 2003 |
| Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5 M Purtscher, A Trkola, A Grassauer, PM Schulz, A Klima, S Döpper, ... Aids 10 (6), 587-594, 1996 | 214 | 1996 |
| An influenza A virus containing influenza B virus 5'and 3'noncoding regions on the neuraminidase gene is attenuated in mice. T Muster, EK Subbarao, M Enami, BR Murphy, P Palese Proceedings of the National Academy of Sciences 88 (12), 5177-5181, 1991 | 183 | 1991 |
| Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis M Salvatore, CF Basler, JP Parisien, CM Horvath, S Bourmakina, H Zheng, ... Journal of virology 76 (3), 1206-1212, 2002 | 181 | 2002 |
| A Genetically Engineered Influenza A Virus with ras-Dependent Oncolytic Properties M Bergmann, I Romirer, M Sachet, R Fleischhacker, A García-Sastre, ... Cancer research 61 (22), 8188-8193, 2001 | 149 | 2001 |
| Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus T Muster, B Ferko, A Klima, M Purtscher, A Trkola, P Schulz, A Grassauer, ... Journal of Virology 69 (11), 6678-6686, 1995 | 144 | 1995 |
| A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1 V Wacheck, A Egorov, F Groiss, A Pfeiffer, T Fuereder, D Hoeflmayer, ... The Journal of infectious diseases 201 (3), 354-362, 2010 | 139 | 2010 |
| Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus A Garcia-Sastre, T Muster, WS Barclay, N Percy, P Palese Journal of virology 68 (10), 6254-6261, 1994 | 99 | 1994 |
| Preclinical evaluation of a replication-deficient intranasal ΔNS1 H5N1 influenza vaccine J Romanova, BM Krenn, M Wolschek, B Ferko, ... PloS one 4 (6), e5984, 2009 | 93 | 2009 |
| Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1 BM Krenn, A Egorov, E Romanovskaya-Romanko, M Wolschek, ... PLoS One 6 (4), e18577, 2011 | 91 | 2011 |
| Interferon resistance promotes oncolysis by influenza virus NS1‐deletion mutants T Muster, J Rajtarova, M Sachet, H Unger, R Fleischhacker, I Romirer, ... International journal of cancer 110 (1), 15-21, 2004 | 84 | 2004 |
